What is Active Pharmaceutical Ingredient and why is it essential for drug manufacturing?
2 years, 4 months ago

What is Active Pharmaceutical Ingredient and why is it essential for drug manufacturing?

Firstpost  

The COVID-19 pandemic caused a panic among global pharmaceutical manufacturers as the supply of APIs was disrupted from China, the world’s largest producer Active Pharmaceutical Ingredients or APIs are essential to the pharma industry. According to pharmaceutical company Biocon, an API means “the biologically active component of a drug product that produces the intended effects”. The COVID-19 pandemic caused a panic among global pharmaceutical manufacturers as the supply of APIs was disrupted from China, the world’s largest producer. According to a PTI report from March this year, 35 APIs which were imported earlier, are being manufactured in India under the Centre’s production linked scheme for the pharma company.

India China Supply Pharmaceutical Pharma Covid Drug Apis Api  china  pandemic  pharma  manufacturing  apis  manufacturers  ingredients  pharmaceutical  drug  active  api  worlds  ingredient  supply  essential

History of this topic

Chinese Pharma Major Shanghai Pharma Seeking API Imports From India
1 month, 4 weeks ago

Chinese Pharma Major Shanghai Pharma Seeking API Imports From India

ABP News  

Shanghai, China: Chinese pharmaceutical giant Shanghai Pharmaceuticals Holding Co. Ltd is keen on importing active pharmaceutical ingredients from India, and is also planning to invest in the Indian market in an effort to expand its footprint in the generic drugs market. In India, more and more APIs are getting FDA approval, so we are now thinking of importing APIs from …

Pharma Star: India Steering Global Supply Chain Away from China - News18
1 year, 1 month ago

Pharma Star: India Steering Global Supply Chain Away from China - News18

News 18  

India’s pharmaceutical industry is at a pivotal juncture. With its well-established prowess in generic drug manufacturing, it has been called on by the world to build a reliable base for the manufacture of raw materials, which offers an opportunity for India to attract the bulk of the pharmaceutical supply chains away from China. “India has started producing 45 APIs after …

India@75: Phenomenal journey of the pharma industry
2 years, 1 month ago

India@75: Phenomenal journey of the pharma industry

Hindustan Times  

The Indian pharmaceutical industry has come a long way since the country’s independence. Among private players, Khwaja Abdul Hamied had already set up one of India’s oldest pharma companies, Cipla in 1935; Indravan Modi set up Cadila pharmaceuticals in the early 1950s, Kallam Anji Reddy set up Dr Reddy’s Laboratories in Hyderabad and Bhai Parvinder Singh set up Ranbaxy in …

Dev 360 | Medicine and frontiers: The challenge that China poses
4 years, 6 months ago

Dev 360 | Medicine and frontiers: The challenge that China poses

Deccan Chronicle  

Can India challenge Chinese dominance in pharmaceutical ingredients? Chinese pharmaceutical companies supported by their government set up large fermentation units to mass-produce bulk drugs and intermediates and, at the same time also established intermediates and bulk drug facilities for manufacturing by chemical synthesis route,” says a 2014 white paper by the Indian Drug Manufacturers’ Association. “Indian pharma companies who were …

How the coronavirus explosed US’ reliance on India and China for generic drugs
4 years, 7 months ago

How the coronavirus explosed US’ reliance on India and China for generic drugs

CNN  

CNN — Sarah Thebarge, a 41-year-old physician assistant living in San Francisco, takes a pill every day to treat her lupus, a chronic condition that causes unbearable joint pain, fatigue and fainting spells. “The scenario really scared me, what would happen to me if I couldn’t get HCQ?” The US Food and Drug Administration has not approved HCQ as the …

Coronavirus outbreak highlighted vulnerabilities in medical manufacturing supply chain: Fitch Solutions
4 years, 8 months ago

Coronavirus outbreak highlighted vulnerabilities in medical manufacturing supply chain: Fitch Solutions

Firstpost  

New Delhi: With pharmaceutical supply chains under immense pressure due to COVID-19, China’s role as a global ingredient producer has come under scrutiny, Fitch Solutions has said. As per the report, as trade war has heightened discussion over the national security implications of manufacturing new technologies abroad, COVID-19 has highlighted vulnerabilities in the medical manufacturing supply chain, most notably in …

COVID-19: India restricts drug exports as threat of coronavirus rises
4 years, 10 months ago

COVID-19: India restricts drug exports as threat of coronavirus rises

The Hindu  

India, the world’s largest maker of generic drugs, on March 3 restricted the export of common medicines such as paracetamol and 25 other pharmaceutical ingredients and drugs made from them, as it looks to prevent shortages amid concerns of the coronavirus outbreak turning into a pandemic. Besides over-the-counter painkiller and fever reducer paracetamol, drugs restricted for exports included common antibiotics …

Coronavirus outbreak: Govt restrains exports of a few APIs, formulations; lists essential medicines that could run out of stock
4 years, 10 months ago

Coronavirus outbreak: Govt restrains exports of a few APIs, formulations; lists essential medicines that could run out of stock

Firstpost  

In a notification, the government put curbs on the exports of certain APIs and formulations, including Paracetamol, Vitamin B1 and B12 amid the coronavirus outbreak claimed over 3,000 lives across the world. CNBC-TV18 newsbreak confirmed, here is the list of APIs that have been put in the list of restriction for exports by the government pic.twitter.com/H0cMra60y1 — CNBC-TV18 March 3, …

Prices of key pharma ingredients may rise if virus impact prolongs
4 years, 10 months ago

Prices of key pharma ingredients may rise if virus impact prolongs

The Hindu  

The prices of key pharmaceutical ingredients could rise if the COVID-19 situation in China does not improve soon, a top company official said on Tuesday. “The prices of active pharmaceutical ingredients could increase if the situation in China does not improve soon,” Zydus Group Chairman Pankaj Patel said. Finance Minister Nirmala Sitharaman on Tuesday met representatives of various sectors, including …

Indian generic drugmakers may face supply shortages from China if coronavirus drags on
4 years, 10 months ago

Indian generic drugmakers may face supply shortages from China if coronavirus drags on

India Today  

Shortages and potential price increases of generic drugs from India loom if the coronavirus outbreak disrupts suppliers of pharmaceutical ingredients in China past April, according to industry experts. An extended outbreak that limits the volume of active ingredients and drugs available for export from China could lead to drug shortages and price increases, particularly in the United States - where …

Discover Related